ARVO Comes to The City of Magic
Highlights from the posters and papers presented at the 2014
ARVO meeting in Orlando.
Mitotech S.A. announces the initiation of phase ii clinical trial in dry eye patients utilizing the controlled adverse environment
SkQ1 proven effective in a topical ophthalmic formulation at preclinical stage of compound development
A Recipe for Better Patient Compliance
How different drug formulations and dosing regimens may help ensure that patients take their medicine.
Wise Choices for Ocular Diagnoses
A look at the value and utility of a range of diagnostic
techniques and technology for anterior segment disease.
What to do when you see red
Here’s what you should know about treating ocular Hyperemia and its underlying cause.
Cool Opportunities to Modulate Nociception
A breakdown of the corneal nerves, how they’re stimulated and
how dry eye, trauma and contact lenses affect them.
Dry-Eye Tests: Reading Is Fundamental
A look at the damage dry eye causes and how reading tests
might be good gauges of the disease’s clinical effects.